WOLVERINE TRADING, LLC - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 316 filers reported holding EDITAS MEDICINE INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q2 2024$206,414
-40.8%
44,200
-6.0%
0.00%
Q1 2024$348,740
-48.8%
47,000
-30.2%
0.00%
-100.0%
Q4 2023$681,749
+85.2%
67,300
+42.6%
0.00%
Q3 2023$368,160
-31.3%
47,200
-28.3%
0.00%
-100.0%
Q2 2023$536,270
+107584.7%
65,800
+17.3%
0.00%0.0%
Q4 2022$498
-100.0%
56,100
-48.5%
0.00%
-50.0%
Q3 2022$1,325,000
+42.3%
108,919
+43.1%
0.00%
+100.0%
Q2 2022$931,000
-61.1%
76,100
-37.9%
0.00%
-66.7%
Q1 2022$2,391,000
-27.3%
122,516
+3.6%
0.00%
-25.0%
Q4 2021$3,287,000
-56.3%
118,287
-33.2%
0.00%
-50.0%
Q3 2021$7,529,000
+18.5%
177,150
+28.5%
0.01%
-20.0%
Q2 2021$6,354,000
+20.6%
137,847
+6.0%
0.01%
+25.0%
Q1 2021$5,270,000
-50.8%
130,102
-7.2%
0.01%
-52.9%
Q4 2020$10,722,000
+506.1%
140,157
+132.4%
0.02%
+240.0%
Q2 2020$1,769,000
+10.9%
60,300
-23.5%
0.01%0.0%
Q1 2020$1,595,000
-40.0%
78,774
-12.6%
0.01%
-28.6%
Q4 2019$2,658,000
+56.2%
90,095
+19.0%
0.01%
+75.0%
Q3 2019$1,702,000
-1.8%
75,738
+8.1%
0.00%
-20.0%
Q2 2019$1,734,000
-20.9%
70,073
-21.8%
0.01%
-16.7%
Q1 2019$2,191,000
+13.2%
89,600
-4.1%
0.01%0.0%
Q4 2018$1,935,000
+87.1%
93,400
+187.4%
0.01%
+100.0%
Q3 2018$1,034,00032,5000.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q4 2020
NameSharesValueWeighting ↓
Deep Track Capital, LP 6,000,000$28,020,0000.84%
Knott David M Jr 177,000$8270.33%
Integral Health Asset Management, LLC 675,000$3,152,2500.30%
Avidity Partners Management LP 816,000$3,810,7200.16%
Green Alpha Advisors, LLC 30,267$141,3470.11%
PDT Partners, LLC 246,537$1,151,3280.11%
Spectrum Planning & Advisory Services Inc. 12,051$57,1220.06%
Woodline Partners LP 970,491$4,532,1930.04%
Hennion & Walsh Asset Management, Inc. 168,371$786,2930.04%
Virtus ETF Advisers LLC 16,489$77,0040.04%
View complete list of EDITAS MEDICINE INC shareholders